SDZ NIM 811 is a cyclosporin A (CsA) analogue that is completely devoid of immunosuppressive capacity but exhibits potent and selective antihuman immunodeficiency virus type 1 (HIV-1) activity. Binding to cyclophilin A, the intracellular receptor for cyclosporins, is a prerequisite for HIV-1 inhibition by cyclosporins. Cyclophilin A was demonstrated to bind to HIV-1 p24 gag and this cyclophilinGag interaction leads to the incorporation of cyclophilin A into HIV-1 virions. SDZ NIM 811 inhibits this protein interaction, and this is likely to be the molecular basis for its antiviral activity. Here, we show that in activated primary T cells SDZ NIM 811 interferes with two stages of the virus replication cycle : (i) translocation of pre-integration complexes
Introduction
Cyclophilin A is a member of the immunophilin class of proteins ; these possess peptidyl-prolyl cis-trans isomerase activity and are therefore believed to be involved in protein folding and\or intracellular transport (Fischer et al., 1989 ; Handschumacher et al., 1984 ; Schreiber & Crabtree, 1992 ; Takahashi et al., 1989 ; Walsh et al., 1992) . The human cyclophilin A protein is encoded by a single gene, which is localized on human chromosome 7p11.2-p13 (Willenbrink et al., 1995) .
Recently, human cyclophilins A and B have been identified as cellular proteins which bind specifically to the human into the nucleus and (ii) production of infectious virus particles. SDZ NIM 811 not only inhibits translocation of HIV-1 pre-integration complexes in primary T cells, but also in a growth-arrested T cell line. In vivo, most T lymphocytes are quiescent, but serve nevertheless as a major and inducible HIV-1 reservoir in infected individuals. Significant amounts of cyclophilin A were found to be associated with virus particles propagated in primary T cells. SDZ NIM 811 caused a strong reduction in the amount of incorporated cyclophilin A, thereby reducing infectivity. Thus, cyclophilin A seems to be necessary for HIV-1 replication in primary T cells.
immunodeficiency virus type 1 (HIV-1) Gag polyprotein, p55 gag (Luban et al., 1993) . Gag proteins play a major role in several steps of the virus life-cycle, including assembly and release of virions (Willis & Craven, 1991) . On release of virions from the host-cell surface the Gag polyprotein is cleaved by the retroviral protease to produce the matrix protein, the capsid protein and the nucleocapsid protein. After fusion of the virus with the host cell and virus uncoating, the genomic RNA is transcribed by HIV reverse transcriptase and the resulting double-stranded DNA is transported to the nucleus where it integrates into the host genome. Several reports suggest that Gag proteins play an important role during these translocation events into the nucleus. It has been reported that HIV-1 preintegration complexes contain matrix proteins (Bukrinsky et al., 1992) , and furthermore, these matrix proteins contain a nuclear localization signal which directs the pre-integration complex to the nucleus (Bukrinsky et al., 1993) . Another cleavage product of the Gag polyprotein, the capsid protein, has been shown to bind specifically to cyclophilin A (Luban et al., 1993 ; Thali et al., 1994 ; Billich et al., 1995) . Notably, several groups have reported that cyclophilin A is functionally associated with HIV-1 virions through interaction with the Gag polyprotein (Franke et al., 1994 ; Thali et al., 1994) . Interestingly, this interaction between cyclophilin A and Gag proteins can be inhibited by the immunosuppressive drug cyclosporin A (CsA), as well as the non-immunosuppressive cyclosporin derivative SDZ NIM 811, thereby inhibiting virus replication Thali et al., 1994 ; Bartz et al., 1995 ; Billich et al., 1995 ; Steinkasserer et al., 1995) .
The mechanism of action of SDZ NIM 811 is clearly not prevention of CD4 + T cell activation Steinkasserer et al., 1995) and is different from that of all other anti-HIV agents described so far. Antiviral efficacy of SDZ NIM 811 has been demonstrated in various cell lines, including primary cells. Replication of several HIV-1 isolates, from different geographical locations, was inhibited in primary cells with IC &! values of 0n011-0n057 µg\ml, while cytostatic effects in proliferating cell lines were detected at concentrations higher than 6 µg\ml .
Previously, we reported that SDZ NIM 811 interferes, after reverse transcription, with two steps in the virus replication cycle : (i) translocation of the pre-integration complex to the nucleus and (ii) assembly of virus particles . To date, all published studies on the antiviral mode of action of CsA and SDZ NIM 811 have focused on T cell lines only. Here, we report for the first time the molecular mode of action of SDZ NIM 811 in primary T cells, i.e. interference with translocation of the pre-integration complex to the nucleus. Furthermore, we find that significant amounts of cyclophilin A are associated with virus particles propagated in primary T cells and that SDZ NIM 811 treatment of primary T cells causes a clear reduction in the amount of incorporated cyclophilin A.
Finally, also in growth-arrested MT4 cells (T cell line), the translocation process of pre-integration complexes was inhibited. Since the cyclophilin A-Gag interaction is inhibited by SDZ NIM 811, this provides further evidence that cyclophilin A is required for virus replication in stimulated, primary T cells, as well as in growth-arrested T cells. It is of note that in vivo, although most of the T cells are quiescent, HIV-1 is nevertheless able to infect these lymphocytes (Bukrinsky et al., 1992 ; Stevenson et al., 1990 ; Zack et al., 1990) .
Methods
Cells and viruses. Primary T lymphocytes were purified from human spleen obtained from healthy donors using a commercial kit (Lympho-Kwik) as described (De Clercq et al., 1994) . Preparations obtained by this procedure contained 60-80 % CD4 + T cells as analysed by fluorescence-activated cell sorting (FACS). MT4 cells (Miyoshi et al., 1981) were maintained in RPMI 1640 medium supplemented with 10 % foetal calf serum (FCS). HIV-1 strain IIIB (HIV-1 IIIB), described by Popovic et al. (1984) , was used for infection of primary T cells and MT4 cells.
SDZ NIM 811. This was obtained by fermentation of the fungus
Tolypocladium niveum (also designated Beauveria nivea), followed by extraction and purification . The compound was 98 % pure as determined by analytical HPLC. Assay of virus production by primary T cells. Cells were stimulated with 2 µg\ml phytohaemagglutinin (PHA ; Sigma) for 24 h. Test compounds [SDZ NIM 811 and zidovudine (AZT)] were added 1 h before virus adsorption. HIV IIIB, at a concentration of 10% TCID &! \ml was adsorbed for 2 h ; the inoculum was then washed away and the infected cells resuspended at a density of 1i10'\ml in culture medium (RPMI, 10 % FCS) containing the test compounds at various concentrations. Test compound was added from a 1000-fold concentrated stock solution in ethanol starting 1 h before virus addition, and was then present throughout the experiment. Every 3 or 4 days, half the medium from the infected cultures was removed and replaced by fresh medium containing the test compounds at the appropriate concentration. At various time-points after infection, cells (1n2i10)) were pelleted by centrifugation and used for DNA preparation as described below. In parallel, total RNA was isolated as previously described (Chirgwin et al., 1979) . Ten µg of total RNA from cells treated with SDZ NIM 811 (3 µg\ml) or AZT (1 µg\ml) was used for first-strand cDNA synthesis (Amersham). One-tenth of this reaction mixture was subsequently used for the PCR amplification (25 cycles) of HIV-1 LTR-specific sequences. In parallel, to standardize RNA amounts, sequences specific for the human eukaryotic initiation factor 5A (eIF-5A) (Koettnitz et al., 1995) were also amplified by PCR (25 cycles). The PCR products were separated by agarose gel electrophoresis and visualized by ethidium bromide staining. The following primer sets were used. LTR primer : sense 5h CCTGT-GAGCCTGCATGGAATGGATG 3h ; antisense 5h TGCTAGAGATT-TTCCACACTGACTAAAAGG 3h ; amplified product 434 bp (for nucleotide positions see below). eIF-5A primer : sense 5h ATGGCAG-ATGACTTGGACTTCGAG 3h (nucleotide position 1995-2018) ; antisense 5h TTATTTTGCCATGGCCTTGATTGCAAC 3h (nucleotide position 3961-3988 ; Koettnitz et al., 1995) ; amplified product 447 bp.
In addition, SDZ NIM 811 (3 µg\ml)-treated as well as untreated infected cells were harvested for the detection of cyclophilin A within the HIV-1 virions, as described below.
DNA isolation. Low and high molecular mass DNA were prepared from uninfected control cells, HIV-1-infected cells, drug-treated and untreated primary T cells and from aphidicolin-treated MT4 cells according to the protocol originally described by Hirt (1967) and the modifications of Gowda et al. (1989) . Briefly, a total of 1n2i10) primary T cells or 2i10( MT4 cells were resuspended in 4 ml TE buffer (25 mM Tris-HCl, pH 7n5 ; 10 mM EDTA) containing 0n6 % SDS. The lysate was kept at room temperature for 10 min, before addition of 1 ml 5 M NaCl and incubation overnight at 4 mC. The extract was centrifuged at 30 000 g for 20 min at 4 mC, after which low molecular mass DNA was isolated from the supernatant, and high molecular mass DNA from the pellet. The Hirt supernatant, containing the low molecular mass DNA fraction, was extracted with an equal volume of phenol-chloroform-isoamyl alcohol followed by chloroform-isoamyl alcohol extraction and a final precipitation at k20 mC overnight. The DNA was recovered by centrifugation, washed in 70 % ethanol and resuspended in 300 µl buffer (10 mM Tris, pH 7n5 ; 100 mM NaCl ; 1 mM EDTA). RNase (200 µg\ml in buffer) was added and incubated for 3 h at 37 mC. After this step, proteinase K (200 µg\ml in 0n5 % SDS) was added to the mixture and incubated for a further 3 h at 37 mC. The DNA was recovered after phenol extraction by ethanol precipitation.
The high molecular mass DNA pellet was then resuspended in 4 ml TE buffer, proteinase K (200 µg\ml in TE buffer) added, and the mixture incubated for 3 h at 50 mC. The DNA was then extracted three times with
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phenol-chloroform-isoamyl alcohol followed by chloroform-isoamyl alcohol extraction and precipitation in ethanol. The DNA was digested with RNase (200 µg\ml) overnight at 37 mC, and then extracted with phenol as described above and precipitated with ethanol. DNA concentrations were determined by reading the absorbance at 260 nm. Prior to this procedure the high molecular mass DNA was digested with the restriction enzyme XbaI in order to allow precise pipetting and determination of DNA concentrations.
PCR analysis of HIV-1-specific sequences in low and high molecular mass DNA fractions. 300 ng of either low or high molecular mass DNA was used for each PCR amplification. DNA samples were subjected to 30 rounds of amplification in a total reaction volume of 50 µl. The following primer sets were used.
Minus-strand strong-stop DNA was detected using the sense LTR primer 5h CCTGTGAGCCTGCATGGAATGGATG 3h (nucleotide position k244 to k220) and the antisense primer 5h TGCTAGAGATT-TTCCACACTGACTAAAAGG 3h (nucleotide position 152-181) ; amplification product 434 bp. Primers for LTR, gag and 2-LTR circles are numbered according to the sequence of Ratner et al. (1990) .
Gag primers amplifying full-length or almost completely synthesized viral DNA : sense primer 5h AGTGGGGGGACATCAAGCAGCCAT-GCAAAT 3h (nucleotide position 903-932) ; antisense primer 5h TGCTATGTCAGTTCCCCTTGGTTCTCT 3h (nucleotide position 1017-1044) ; amplification product 142 bp.
For detection of the 2-LTR circles the sense primer 5h CCTTTTA-GTCAGTGTGGAAAATCTCTAGCA 3h (nucleotide position 152-181) and the antisense primer 5h CAGTGGGTTCCCTAGTTAGC 3h (nucleotide position 44-63) were used ; amplified product 536 bp (Bukrinsky et al., 1992) .
Mitochondrial primer : sense 5h GAATGTCTGCACAGCCACTTT 3h (nucleotide position 247-267) ; antisense 5h ATAGAAAGGCT-AGGACCAAAC 3h (nucleotide position 653-673) ; amplified product 427 bp (Stevenson et al., 1990) .
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) primer : sense 5h CCACCCATGGCAAATTCCATGGCA 3h (nucleotide position 227-250) ; antisense 5h TCTAGACGGCAGGTCAGGTCCACC 3h (nucleotide position 801-824) (Ercolani et al., 1998) .
After PCR amplification, the 2-LTR circle PCR products from MT4 cells were separated by agarose gel electrophoresis and visualized using ethidium bromide staining. 2-LTR circle products from primary T cells were analysed in Southern blot experiments with an α-$#P-labelled HIV-1 IIIB-specific cDNA probe (Maniatis et al., 1982) . The LTR-, gag-, mitochondrial-and GAPDH-amplification products were separated on agarose gel and visualized by ethidium bromide staining. The amounts of amplified mitochondrial DNA-and GAPDH signal were used as internal PCR standards for low and high molecular mass DNA amplification, respectively.
Detection of cyclophilin A in virions propagated in primary T cells.
The cyclophilin A content of viral particles derived from infected primary T cells was analysed directly by SDS-PAGE and subsequent Western blotting. At day 12 post-infection, 3i10) cells were harvested from the SDZ NIM 811-treated and untreated groups. Cells were pelleted at 2500 r.p.m. for 10 min and the supernatant subsequently ultracentrifuged at 45 000 r.p.m. for 1 h at 4 mC. The pellet was dissolved in gel loading buffer (0n13 M Tris, pH 6n8 ; 4 % SDS ; 10 % 2-mercaptoethanol ; 20 %, v\v, glycerol ; 0n004 % bromphenol blue). SDS-PAGE was done on gels containing 20 % acrylamide using the Pharmacia Phast System. Gels were blotted onto nitrocellulose membranes. After incubation with rabbit anti-cyclophilin antibodies, reactive bands were visualized with biotinylated anti-rabbit IgG antibodies followed by the ECL detection system (Amersham) and exposure to X-ray film. Band intensities were quantified with an LKB laser densitometer. Polyclonal antibodies against purified human cyclophilin A were raised in rabbits and purified via DEAE-Sephadex and Protein A-Sepharose (Pharmacia) chromatography. In order to normalize for virion quantity, treated and untreated samples were also probed with a rabbit polyclonal p24 antiserum and visualized as described above.
De novo infection of aphidicolin-treated MT4 cells. Twentyfour hours before infection with virus, MT4 cells were growth-arrested by incubation in the presence of 5 µg\ml aphidicolin (Sigma). To demonstrate the effectiveness of the aphidicolin treatment, MT4 cells were incubated in medium both with and without aphidicolin and then analysed for [$H]thymidine incorporation as described (Bukrinsky et al., 1992) . Cell survival was monitored by trypan blue staining. For de novo infection HIV-1 IIIB, at a concentration of 10% TCID &! \ml, was adsorbed to growth-arrested MT4 cells for 1 h ; the inoculum was then removed by washing and the infected cells were resuspended at a density of 5i10&\ml in culture medium. Test compound was added 1 h before addition of virus and was present throughout the experiment. After HIV-1 infection, 2i10( cells per analysis and time-point were pelleted by centrifugation and used for DNA preparation and PCR analysis as described above.
Results
Effect of SDZ NIM 811 on viral RNA production and host-cell function
The effect of SDZ NIM 811 on the HIV-1 replication cycle in primary T cells was investigated using a high concentration of virus inoculum. Viral RNA synthesis was analysed by RT-PCR 12 days post-infection using an HIV-1 LTR-specific primer set. SDZ NIM 811 at 3 µg\ml significantly inhibited production of viral RNA (Fig. 1, upper panel, lane 2) ; AZT at 1 µg\ml abolished viral RNA production almost completely (Fig. 1, upper panel, lane 1) . In order to demonstrate that SDZ NIM 811 at 3 µg\ml is not cytotoxic for host function, the amount of cellular eIF-5A-specific mRNA was determined. No effect on the transcription of cellular eIF-5A-specific mRNA was detectable in the presence of SDZ NIM 811 and AZT at the given concentrations (Fig. 1, lower panel) . Therefore, we conclude that the effects of SDZ NIM 811 at 3 µg\ml in primary T cells are not a consequence of drug toxicity to the cells.
Shedding of p24 (pg\ml) to the supernatant was analysed starting from day 4 post-infection. In the untreated control group 4400 pg\ml of p24 was detected on day 4. The p24 concentration increased to 9200 pg\ml on day 7, to 47 800 pg\ml on day 11 and up to 54 600 pg\ml on day 14. SDZ NIM 811 inhibited p24 antigen production in a dosedependent manner. At SDZ NIM 811 concentrations of 3, 1 and 0n3 µg\ml, 100, 100 and 200 pg\ml of p24 were detected respectively on day 4, 200, 200 and 6700 pg\ml on day 7, and 2000, 2200 and 30 300 pg\ml on day 11, whereas 15 200, 17 900 and 42 600 pg\ml were detected on day 14, at the respective SDZ NIM 811 concentrations (see Table 1 ). , infected with HIV-1 IIIB, were harvested after 12 days and total RNA was isolated. Samples of RNA derived from HIV-1-infected, SDZ NIM 811-treated (3 µg/ml) as well as AZT-treated (1 µg/ml) T cells were reverse transcribed and used for RT-PCR analysis with an HIV-1 LTR-specific PCR primer set (upper panel). A strong signal was obtained from the untreated HIV-1-infected primary T cells. SDZ NIM 811 reduced viral RNA production significantly. AZT abolished viral RNA production very effectively. Lower panel : to control cellular RNA amounts, the same probes were analysed using an oligonucleotide primer set specific for the eukaryotic initiation factor 5A (eIF-5A). Standards for HIV-1 LTR were generated by PCR using log dilutions of cloned HIV-1 IIIB DNA (see also Figs 2, 3 and 5). Standards for eIF-5A were generated by PCR using log dilutions of cell equivalents.
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Analysis of low molecular mass DNA produced in the absence and presence of SDZ NIM 811 in primary T cells
Primary T cells were infected with 10% TCID
&! of HIV-1 IIIB, in the presence of different concentrations of SDZ NIM 811. AZT, a reverse transcriptase inhibitor, was included as a control. Low molecular mass DNA was isolated from infected untreated (positive control) and infected drug-treated cells, as well as from mock-infected cultures (negative control) and analysed by PCR 4, 8 and 11 days post-infection. SDZ NIM 811 inhibited the formation of 2-LTR circles in a concentrationdependent manner (Fig. 2 a) . After 4 and 8 days no PCR products could be detected in cells treated with 1 or 3 µg\ml respectively, whereas a positive signal was observed in the untreated cell population. After 11 days of SDZ NIM 811 treatment, the antiviral effect was very prominent, as indicated by a comparison with the intensity of the signal for the untreated control, which had increased considerably. Furthermore, a dose-dependence of the inhibitory effect of SDZ NIM 811 was evident. The PCR analysis of AZT-treated samples is shown in Fig. 2 (b) . No 2-LTR circle product was amplified from the 0n03 µg\ml-treated samples at any timepoint, whereas a strong positive signal was observed in the untreated cell control populations, especially 8 and 11 days post-infection. Faint 2-LTR circle products were detectable after 11 days only at 0n01 µg\ml AZT (Fig. 2 b) . In order to show that reverse transcription had occurred in the presence of SDZ NIM 811, gag-specific sequences were amplified from day 4 and day 8 samples (Fig. 2 c) . No major differences were observed between treated and untreated samples. PCR standards for the 2-LTR amplification, and mitochondrial DNA amplification, used as internal PCR standards, are shown in Fig.  2 (d) and 2 (e), respectively.
Analysis of high molecular mass DNA produced in the absence and presence of SDZ NIM 811 in primary T cells
The effect of SDZ NIM 811 on the translocation of viral DNA into the nucleus and subsequent integration into the host genome was analysed by PCR with the high molecular mass DNA preparations as template. For this experiment, the LTR primer set was used and the inhibitory activity of SDZ NIM 811 was again compared with that of AZT. A clear reduction of integrated viral DNA was detectable in the presence of SDZ NIM 811, particularly at 3 µg\ml (Fig. 3 a) . Comparable results were obtained when a gag-specific PCR primer set was used , amplifying only full-length or almost completely synthesized viral DNA (data not shown). Similarly effective inhibition was seen with AZT ( Fig. 3 b) . These PCR bands are genuine high molecular mass DNA amplification products and are not derived from low molecular mass DNA contamination. In the case of contamination one would expect the same signal in treated and untreated samples, but this is clearly not the case. The primer set amplifying GAPDH sequences served as an internal PCR standard for amplification of high molecular mass DNA (Fig. 3 c) .
Detection of cyclophilin A associated with HIV-1 virions produced by primary T cells
Next, the amount of cyclophilin A associated with HIV-1 viral particles derived from primary T cells was assessed. Cells were infected with HIV-1 IIIB (10% TCID &! \ml) and 3i10) cells were harvested at day 12 post-infection. These primary T cells were cultured either in the presence of SDZ NIM 811 (3 µg\ml) or left untreated. Virions released into the supernatant were pelleted by ultracentrifugation and identical amounts of virions (normalized by p24 ; see Fig. 4 b) were analysed by SDS-PAGE and Western blotting. These analyses revealed that significant amounts of cyclophilin A are associated with virus particles in the absence of compound (Fig. 4 a, lane A) . In contrast, the SDZ NIM 811-treated group showed a clear reduction in the amount of incorporated cyclophilin A (Fig. 4 a, lane B) . Quantification of these cyclophilin A bands revealed a reduction of cyclophilin A content in the SDZ NIM 811-treated virions of greater than 60 %. In order to normalize for virion quantity, the same treated and untreated samples were also examined with p24 antiserum. No difference was found between the two groups (Fig. 4 b) . In order to verify that the cyclophilin A bands are virion-associated and not due to cellular contamination, uninfected cells were subjected to the same experimental procedure as infected cells. No cyclophilin signal was detectable in these samples (Fig. 4 a, lane C) . Furthermore, if the cyclophilin A band identified in the infected samples was derived from cellular contamination one would expect the same signal intensity in both the treated and untreated groups, which is clearly not the case.
Using Jurkat cells chronically infected with HIV-1 (strain IIIB) similar effects on cyclophilin A incorporation were obtained (A. Billich, unpublished results). Virions derived from SDZ NIM 811 (3 µg\ml)-treated Jurkat\IIIB cells gave a 65 % reduction in cyclophilin A content in comparison with untreated cells. In these experiments the same analytical procedure as described above for primary T cells was used. Bukrinsky et al. (1992) . Trypan blue staining confirmed the high viability of aphidicolin-treated cells. The growth-arrested cells were then infected with HIV-1 IIIB (10% TCID &! \ml), in the presence or absence of SDZ NIM 811 or AZT. At various time-points after infection (8, 30, 54 h), 2i10( cells were pelleted by centrifugation. Then, low molecular mass DNA was prepared and analysed by PCR. SDZ NIM 811 inhibited the formation of 2-LTR circles in a concentration-dependent manner (Fig. 5 a) . After 8 h almost no PCR products could be detected in the presence of 1 or 3 µg\ml SDZ NIM 811, whereas a positive signal was observed in the untreated virus control group. After 30 and 54 h, the inhibitory effect became even more pronounced. The intensity of the signal for the untreated control group increased considerably in comparison with the drug-treated one. The PCR analysis of AZT-treated samples is shown in Fig. 5 (b) , and demonstrates a clear inhibitory effect of AZT.
In order to show that reduction in 2-LTR circle formation in these growth-arrested cells is not due to reduction in virus binding or entry, or to inhibition of reverse transcriptase, PCR analyses of the same DNA samples as above were performed using the LTR primer set. There were only minor differences in the amplification of LTR-specific sequences between SDZ NIM 811-treated and untreated samples (Fig. 5 c) . Comparable results were obtained using a gag-specific PCR primer set (data not shown). These results show that the extent of HIV adsorption, penetration and de novo synthesis of viral DNA in growth-arrested cells, as in the case of replicating MT4 cells , is not impaired by SDZ NIM 811. Together, these data support the conclusion that the reduction of formation of 2-LTR circles by SDZ NIM 811 is due to a reduction in nuclear import. Amplification of mitochondrial DNA was included as an internal low molecular mass DNA PCR standard (Fig. 5 d) .
Discussion
The CsA analogue SDZ NIM 811 is completely devoid of immunosuppressive activity but exhibits potent and specific anti-HIV-1 activity Steinkasserer et al., 1995) . Its antiviral effect, which is shared by CsA, is mechanistically clearly different from that of other antiviral agents described so far. It has been reported that the Gag polyprotein of HIV-1 binds to cyclophilin A and B (Luban et al., IDB E. Mlynar and others E. Mlynar and others NIM 811-treated Jurkat cells, contained amounts of capsid proteins, reverse transcriptase activity and viral RNA comparable with those of the untreated control, they were less infectious Steinkasserer et al., 1995) . As shown in Fig. 4 (Franke et al., 1994 ; Thali et al., 1994) . In T cells that had been growth-arrested by aphidicolin treatment, efficient nuclear transport of proviral DNA and establishment of productive HIV-1 infection were observed. This suggests that a particular cellular activation state, rather than the process of cell activation itself, is required for a productive viral infection (Bukrinsky et al., 1992 ; Li et al., 1993) . In order to analyse the effects of SDZ NIM 811 on virus synthesis in growth-arrested T cells, MT4 cells were arrested in the cell cycle by incubating them in the presence of aphidicolin. These cells were then infected with HIV-1 in either the presence or absence of SDZ NIM 811. In growth-arrested T cells HIV-1 reverse transcription of viral DNA and nuclear import of viral pre-integration complexes still occurred (see Fig. 5 , untreated viral controls). However, SDZ NIM 811 inhibited the translocation of pre-integration complexes into the nucleus in a concentration-dependent manner (see Fig. 5 a) . This effect is not due to reduction in virus binding, entry or inhibition of reverse transcription by SDZ NIM 811 (see Fig.  5 c) . These data support the conclusion that the reduction of 2-LTR circle formation by SDZ NIM 811 is due to a reduction of nuclear import.
In vivo, most T lymphocytes are non-proliferating, but can nevertheless serve as a major and inducible HIV-1 reservoir in infected individuals (Bukrinsky et al., 1992 ; Li et al., 1993) . In monocyte-derived macrophages cellular requirements for productive HIV-1 infection are the same as in T cells (Schuitemaker et al., 1994) . Hence, one could envisage a similar mode of action of SDZ NIM 811 in primary macrophages as in T cells.
Since cyclophilin A is a cellular protein one could speculate that SDZ NIM 811-resistant mutants would develop only very slowly in primary cells. Whether this is indeed the case remains to be seen, although in CD4 + HeLa cells resistance is developed rapidly (Aberham et al., 1996) . Further studies are required to show if these effects are cell line-dependent and whether mutant viruses incorporate cyclophilins into virions and are resistant to SDZ NIM 811-mediated inhibition of nuclear entry. The resistant phenotype of these mutants is, however, not expressed in the T cell line MT4, in primary T cells and in E. Mlynar and others E. Mlynar and others monocytes\macrophages (B. Rosenwirth, unpublished results) . In these cells the mutants are sensitive to inhibition by SDZ NIM 811.
In conclusion, we propose that interference with the HIV-1 Gag-cyclophilin A interaction is the molecular basis for the antiviral activity of SDZ NIM 811. The results that (i) it interferes with the formation of 2-LTR circular viral DNA, and (ii) virus particles produced in the presence of SDZ NIM 811 contain less cyclophilin A and are, therefore, less infectious, may be explained by the following hypothesis. Cyclophilin A plays an essential role in the early steps of the virus replication cycle, e.g. by inducing a conformational change in p24 which may cause removal of this protein from the pre-integration complex. This conformational change may render the complex able to reach a cellular location where the viral DNA can be ligated (probably the nucleus), or alternatively, it makes the DNA in the complex accessible to ligases. This function can be performed only by cyclophilin A molecules carried within the virus core particle. Lack of incorporation of cyclophilin A into virus particles in the presence of SDZ NIM 811 would lead to a defect in early processes of infection with these particles. The presence of SDZ NIM 811 during the early replication steps of intact entering viruses would also block the function of the particle-associated cyclophilin A and would thereby interfere with these steps.
